about
Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomasMicrosatellite analysis in cutaneous malignant melanoma.Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.Radiation-induced cutaneous carcinoma of the head and neck: is there an early role for p53 mutations?Analysis of protease-activated receptor-1 and -2 in human scar formation.Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis.Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases.The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo.Middle ear adenoma is an amphicrine tumor: why call it adenoma?Defining early mycosis fungoides.BRAF and KIT somatic mutations are present in amelanotic melanoma.Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesisPrimary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.Sinonasal carcinomas: recent advances in molecular and phenotypic characterization and their clinical implications.Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop.A ribonuclease protection assay-based approach for analysis of angiogenic gene expression in archival tissues.Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease.A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides.Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma.Cutaneous lymphoma: a clinically relevant classification.Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force StudHuman generalized argyria: a submicroscopic and X-ray spectroscopic study.The role of apoptosis in the pathogenesis of dermatitis herpetiformis.Photoexposition discriminates Notch 1 expression in human cutaneous squamous cell carcinoma.Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.Detection of Epstein-Barr viral genome in tumor cells of Warthin's tumor of parotid gland.Epstein-Barr virus (EBV) infection and undifferentiated carcinoma of the parotid gland in Caucasian patients.Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection.Intestinal metaplasia of the sinonasal mucosa adjacent to intestinal-type adenocarcinoma. A morphologic, immunohistochemical, and molecular study.Epidermal growth factor receptor expression and gene copy number in sinonasal intestinal type adenocarcinoma.Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis.Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.[Prognostic factors in thin cutaneous malignant melanoma]Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments.Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type.KIT genetic alterations in anorectal melanomas.Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous LymphomasGranulomatous Mycosis Fungoides and Granulomatous Slack SkinIncrease in FOXP3+ Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response
P50
Q28266547-83382B1D-1F22-4D96-817B-3059526AEBA4Q30872375-321E9811-1006-4EDD-A488-ACD98AC5B58CQ33232622-E80597F3-82FB-4C2E-AE4A-19F6F77084BFQ33249067-17C91C31-FFB5-447A-B487-3C7069BBB046Q33289128-EE5EAE5A-04DF-41B6-B233-2B6765B01C4AQ33355483-E8935FC8-5694-4794-AE40-04C222709597Q33526634-9ECE4B8B-73A2-4D66-B35D-6B02B3BF70DEQ33755643-8D89CAC6-09F3-4471-B9D6-A9154F43E088Q33942003-D7991698-9612-4E55-92E9-D6A65953285CQ34470437-B3824217-A1C5-4203-933A-BD7400B7DC4BQ34931811-1514137E-F720-423D-A2C0-724E4E6FD0FFQ34955908-4638DAF5-1EA2-4442-8D10-0470D06FE9A4Q35398309-08E21795-2157-44B5-A813-6F936F699C6EQ37373066-A62013CE-FD6A-4E97-BA4A-7D8903986998Q37792606-4AECC3CF-1DDD-451F-9BC1-6A9C64F04994Q38179483-6BC07994-4C38-4786-B88C-8BB8C5B42F30Q38430664-938C4CCE-67D7-4E97-A623-0705C1ADFF01Q38892071-022AE58A-CADB-48FF-B289-5F980F4CEC43Q39014399-F4473DBE-6B1D-4FD3-8298-35F901AA4E3FQ40352864-309195F4-86E4-4CEF-B229-5567B61CD7D8Q40774277-9415AE9F-1974-41AE-8CEB-1B73ACC88C79Q41086530-FCF811E5-0A63-44E0-BF7B-2110598F3E49Q42451787-2693F846-7C0F-4A88-95F5-AC703DCDC34AQ42488808-C43563F8-3A2F-44E8-91B7-8A5F293CD3D9Q42523570-59FC53E5-0446-4338-8AA3-C7DD3AF1E6C1Q44197100-2E61CD1C-05AE-4C36-8237-E61BE3C3F109Q44661465-69E999CB-7D6C-4ACE-B5B8-3014ADCD5AACQ45784525-C83CA781-C25E-4AC9-AB37-0C41A4211BBAQ47420861-35A5B5B3-E294-4B0B-8D93-6F2764DF4CBEQ51681410-C89F9ECC-40A7-47B5-82D1-63BE7DDA6A64Q51824693-B655B082-2D6E-4A08-B00A-6D381468B063Q52936572-97DD3673-E761-4170-9C48-6C9A4F053F89Q53425038-6256853F-AEB5-4A18-87FD-B232060E2107Q54154103-49837ACC-41DB-4B34-A45B-DAE3733570D2Q54440196-B605C7EE-5DA2-40D0-A5F0-8543AE612C83Q54787009-98A5C285-2F5C-4DC4-ADC2-E631D24488E9Q55070218-341CEFB8-E6C5-42E3-A8A3-A04565D6F34AQ56998505-41098D74-FE70-4E1C-89F4-9761A86EE181Q58482125-AF03250D-6453-4D57-AB6E-6A28EAA1AEBDQ59558902-B750E9A1-F6BC-4B13-8946-68D3F57AAEDE
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Marco Santucci
@ast
Marco Santucci
@en
Marco Santucci
@es
Marco Santucci
@nl
type
label
Marco Santucci
@ast
Marco Santucci
@en
Marco Santucci
@es
Marco Santucci
@nl
prefLabel
Marco Santucci
@ast
Marco Santucci
@en
Marco Santucci
@es
Marco Santucci
@nl
P1153
7102828232
P31
P496
0000-0003-3882-8842